
Please try another search
By Alun John and Lucy Raitano LONDON (Reuters) - Shares of surprise tariff avoiders like pharmaceuticals and drinks firms and rate-sensitive stocks such as real estate were among the few to post...
GuruFocus - Cash, Cash Equivalents, and Marketable Securities: Approximately $4 million as of December 31, 2024.Research and Development Expenses: $6.2 million for the year ended December 31, 2024,...
Investing.com -- AstraZeneca (NASDAQ:AZN), a leading pharmaceutical company, announced on Monday that it plans to acquire biotechnology firm EsoBiotec in a deal that could reach up to $1...
LONDON - AstraZeneca PLC (LON:AZN) announced that its 2025 Annual General Meeting (AGM) will be hosted digitally on April 11 at 14:30 (BST). The Notice of AGM and Shareholders' Circular has been...
LONDON - AstraZeneca PLC (LON:AZN) and Daiichi Sankyo's Enhertu has been recommended for approval by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA)....
LONDON - AstraZeneca PLC (LSE/STO/Nasdaq: LON:AZN), the UK-based biopharmaceutical company, has published its Annual Report and Form 20-F Information for the year 2024. The report, which details the...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review